Related Experiment Video
Updated: Oct 18, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
COVID-19 and Sepsis
Zeliha Koçak Tufan1,2,3, Bircan Kayaaslan1, Mervyn Mer4
1Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey
Severe COVID-19 shares similarities with sepsis, involving multi-organ involvement and a cytokine storm. Recognizing COVID-19 as a sepsis syndrome aids in developing treatments to manage immune response and improve patient outcomes.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pathology
Background:
- The COVID-19 pandemic has significantly impacted medical literature, particularly discussions on sepsis.
- Many acute manifestations of COVID-19 resemble sepsis caused by other pathogens, necessitating updates to existing definitions to include SARS-CoV-2.
- Severe COVID-19 exhibits high serum cytokine and chemokine levels, akin to sepsis, indicating a systemic inflammatory response.
Purpose of the Study:
- To analyze the similarities and differences between COVID-19 and traditional sepsis.
- To explore the pathogenesis of severe COVID-19, including multi-organ involvement and hypercoagulability.
- To evaluate the relevance of considering severe COVID-19 as a sepsis syndrome for treatment strategies.
Main Methods:
- Review of existing literature and autopsy findings in hospitalized COVID-19 patients.
- Analysis of laboratory parameters (cytokines, chemokines, D-dimer, ferritin, CRP) in severe COVID-19.
- Comparison of clinical and laboratory features of COVID-19 sepsis with bacterial sepsis and hemophagocytic lymphohistiocytosis (HLH).
Main Results:
- COVID-19 involves multiple organs beyond the lungs, with autopsy showing vascular damage, ARDS, and inflammatory infiltration.
- Severe COVID-19 cases display hypercoagulability, involving Virchow's triad, and laboratory alterations suggestive of a cytokine storm.
- Significant overlap exists between SARS-CoV-2 induced cytokine storm and HLH, with viral sepsis showing distinct features from bacterial sepsis regarding systemic inflammation and clinical course.
Conclusions:
- Severe COVID-19 can be conceptualized as a sepsis syndrome, sharing key pathophysiological mechanisms with traditional sepsis.
- Understanding COVID-19 as sepsis aids in developing targeted treatments to modulate the immune response and mitigate organ damage.
- Further research into viral sepsis pathogenesis is crucial for optimizing patient management and improving outcomes in severe COVID-19 cases.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Asepsis

